Back to search
FDAFDA · Food and drugs·Recall number Z-0444-2021

SUNG HWAN E&B VIVACE Shenb Innovation of Beauty Technologyt - Product Usage: intended for use in the dermatologic and surgical procedures for electrocoagulation and hemostasis, and the percutaneous treatment of facial wrinkles.

Published November 18, 2020 · Recall initiated: March 13, 2020

Summary

FDA records medical device Class II recall Z-0444-2021, published November 18, 2020 and initiated March 13, 2020. Recalling firm: Aesthetics Biomedical, Inc.; Status: Terminated; Reported quantity: 623 units; Lot: UDI Code: 08800017100326 All Lots/Serial Numbers: Serial Number range from 16019 to 20121. The Vivace Electrosurgical System is controlled by software system: VIVA-MA-01, V 1.0, Class B. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

A high frequency output (2 MHz) has not been cleared for distribution in the U.S.

What to do

Voluntary: Firm initiated · E-Mail

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Aesthetics Biomedical, Inc.
Distributor
U.S. Nationwide distribution including in the states of AL, AZ, CA, CO, CT, DC, DE, FL, GA, HI, IA, ID, IL, IN, KS, KY, LA, MA, MD, ME, MI, MN, MO, MS, MT, NC, NE, NH, NJ, NM, NY, OH, OK, OR, PA, RI, SC, SD, TN, TX, UT, VA, WA, WI, and WY.
Lot
UDI Code: 08800017100326 All Lots/Serial Numbers: Serial Number range from 16019 to 20121. The Vivace Electrosurgical System is controlled by software system: VIVA-MA-01, V 1.0, Class B
Risk classification
Class II
Area (FDA)
device
Country
United States

Related recalls

Questions about this recall

Was SUNG HWAN E&B VIVACE Shenb Innovation of Beauty Technologyt - Product Usage: intended for use in the dermatologic and surgical procedures for electrocoagulation and hemostasis, and the percutaneous treatment of facial wrinkles. recalled?

Yes. FDA published recall Z-0444-2021 on November 18, 2020. Reported hazard: A high frequency output (2 MHz) has not been cleared for distribution in the U.S.

What should I do if I have this product?

Voluntary: Firm initiated · E-Mail